Structured Data Capture, published by HL7 International / FHIR Infrastructure. This guide is not an authorized publication; it is the continuous build for version 4.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/sdc/ and changes regularly. See the Directory of published versions
Official URL: http://hl7.org/fhir/uv/sdc/Questionnaire/questionnaire-sdc-profile-example-loinc | Version: 4.0.0-ballot | |||
Standards status: Informative | Computable Name: MedicationorOtherSubstance | |||
Other Identifiers: http://loinc.org/vs#74080-3, OID:2.16.840.1.113883.4.642.40.17.35.13 |
Generated Narrative: Questionnaire questionnaire-sdc-profile-example-loinc
LinkID | Text | Cardinality | Type | Flags | Description & Constraints |
---|---|---|---|---|---|
MedicationorOtherSubstance | Questionnaire | http://hl7.org/fhir/uv/sdc/Questionnaire/questionnaire-sdc-profile-example-loinc#4.0.0-ballot | |||
Medication/header | null | 0..1 | group | ||
0 | Form ID: | 1..1 | string | ||
74080-3/74081-1 | Event ID: | 1..1 | string | ||
74080-3/30947-6 | Initial Report Date (HERF Q1) | 1..1 | string | ||
Medication/SEC00 | Medication or Other Substance | 0..1 | group | ||
Medication/SEC00.0 | Use this form to report any patient safety event or unsafe condition involving a substance such as a medications, biological products, nutritional products, expressed human breast milk, medical gases, or contrast media. Do not complete this form if the event involves appropriateness of therapeutic choice or decision making (e.g., physician decision to prescribe medication despite known drug-drug interaction). If the event involves a device, please also complete the Device or Medical/Surgical Supply including Health Information Technology (HIT) form. Narrative detail can be captured on the Healthcare Event Reporting Form (HERF). | 0..1 | display | ||
Medication/SEC01/74080-3 | null | 1..1 | group | ||
74080-3/74076-1 | 1.. What type of medication/substance was involved? | 1..1 | choice | Definition: http://loinc.org/74076-1 Value Set: AHRQ_Medication_Q1 | |
74080-3/74075-3 | 2.. What type of medication? | 1..1 | choice | Definition: http://loinc.org/vs/74075-3 Enable When: 74080-3/74076-1 = Value Set: AHRQ_Medication_Q2 | |
74080-3/74077-9-q | 3.. Please list all ingredients: | 1..* | string | Definition: http://loinc.org/74077-9 Enable When: 74080-3/74075-3 = | |
74080-3/74074-6 | 4.. What type of biological product? | 0..1 | choice | Enable When: 74080-3/74076-1 = Value Set: AHRQ_Medication_Q4 | |
74080-3/30959-1 | 5.. What was the lot number of the vaccine? | 1..1 | string | Enable When: 74080-3/74074-6 = | |
74080-3/74073-8 | 6.. What type of nutritional product? | 1..1 | choice | Enable When: 74080-3/74076-1 = Value Set: AHRQ_Medication_Q6 | |
74080-3/74073-8/Other/Specify | null | 1..1 | string | Enable When: 74080-3/74073-8 = | |
74080-3/74076-1/Other/Specify | null | 1..1 | string | Enable When: 74080-3/74076-1 = | |
74080-3/74072-0 | 7.. Which of the following best characterizes the event? | 1..1 | choice | Enable When: Value Set: AHRQ_Medication_Q7 | |
74080-3/74071-2 | 8.. What was the incorrect action? | 0..1 | choice | Enable When: 74080-3/74072-0 = Value Set: AHRQ_Medication_Q8 | |
74080-3/74070-4 | 9.. Which best describes the incorrect dose(s)? | 1..1 | choice | Enable When: 74080-3/74071-2 = Value Set: AHRQ_Medication_Q9 | |
Medication/74069-6 | 10.. Which best describes the incorrect timing? | 1..1 | choice | Enable When: 74080-3/74071-2 = Value Set: AHRQ_Medication_Q10 | |
74080-3/74068-8 | 11.. Which best describes the incorrect rate? | 1..1 | choice | Enable When: 74080-3/74071-2 = Value Set: AHRQ_Medication_Q11 | |
Medication/74067-0 | 12.. Which best describes the incorrect strength or concentration? | 1..1 | choice | Enable When: 74080-3/74071-2 = Value Set: AHRQ_Medication_Q12 | |
Medication/74066-2 | 13.. What was the expiration date? | 1..1 | string | Enable When: 74080-3/74071-2 = | |
Medication/74065-4 | 14.. Was there a documented history of allergies or sensitivities to the medication/substance administered? | 1..1 | choice | Enable When: 74080-3/74071-2 = Value Set: AHRQ_Y/N/UNK | |
Medication/74064-7 | 15.. What was the contraindication (potential or actual interaction)? | 1..1 | choice | Enable When: 74080-3/74071-2 = Value Set: AHRQ_Medication_Q15 | |
Medication/74064-7/Other/Specify | null | 1..1 | string | Enable When: Medication/74064-7 = | |
74080-3/74071-2/Other/Specify | null | 1..1 | string | Enable When: 74080-3/74071-2 = | |
74080-3/74063-9 | 16.. At what stage in the process did the event originate, regardless of the stage at which it was discovered? | 1..1 | choice | Enable When: 74080-3/74072-0 = Value Set: AHRQ_Medication_Q16 | |
74080-3/74063-9/Other/Specify | null | 1..1 | string | Enable When: 74080-3/74063-9 = | |
74080-3/74078-7.0 | Please provide the following medication details for any medications or other substances directly involved in the event. | 0..1 | display | ||
74080-3/74078-x | For an near miss, omit question 27 | 0..1 | display | Enable When: 74080-3/74072-0 != | |
74080-3/74078-7 | null | 1..* | group | Enable When:
| |
74080-3/74078-7/74062-1 | 17.. Generic name or investigational drug name | 0..1 | string | ||
74080-3/74078-7/74061-3 | 18.. Ingredient RXCUI (if known) | 0..1 | string | ||
74080-3/74078-7/74060-5 | 19.. Brand name (if known) | 0..1 | string | ||
74080-3/74078-7/74059-7 | 20.. Brand name RXCUI (if known) | 0..1 | string | ||
74080-3/74078-7/74058-9 | 21.. Manufacturer (if known) | 0..1 | string | ||
74080-3/74078-7/74057-1 | 22.. Strength or concentration of product | 0..1 | string | ||
74080-3/74078-7/74056-3 | 23.. Clinical drug component RXCUI (if known) | 0..1 | string | ||
74080-3/74078-7/74055-5 | 24.. Dosage form of Product | 0..1 | string | ||
74080-3/74078-7/74054-8 | 25.. Dose form RXCUI (if known) | 0..1 | string | ||
74080-3/74078-7/74053-0 | 26.. Was this medication/substance prescribed for this patient? | 1..1 | choice | Enable When: 74080-3/74072-0 != Value Set: AHRQ_Y/N | |
Medication/74052-2 | 27.. Was this medication/substance given to this patient? | 1..1 | choice | Enable When: 74080-3/74072-0 != Value Set: AHRQ_Y/N | |
Medication/SEC03 | null | 0..1 | group | Enable When: 74080-3/74072-0 = | |
74080-3/74051-4 | 28.. What was the intended route of administration? | 1..1 | choice | Value Set: AHRQ_Medication_Q28_Q29 | |
74080-3/74051-4/Other/Specify | null | 1..1 | string | Enable When: 74080-3/74051-4 = | |
74080-3/74050-6 | 29.. What was the actual route of administration (attempted or completed)? | 1..1 | choice | Value Set: AHRQ_Medication_Q28_Q29 | |
74080-3/74050-6/Other/Specify | null | 1..1 | string | Enable When: 74080-3/74050-6 = | |
Medication/SEC04 | Thank you for completing these questions. | 0..1 | group | ||
Medication/SEC04.0 | OMB No. 0935-0143 Exp. Date 10/31/2014 Public reporting burden for the collection of information is estimated to average 10 minutes per response. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: AHRQ Reports Clearance Officer, Attention: PRA, Paperwork Reduction Project (0935-0143), AHRQ, 540 Gaither Road, Room #5036, Rockville, MD 20850. | 0..1 | display | ||
Reporting | Reporting information | 0..1 | group | ||
Reporting/who | Reported by: | 0..1 | string | ||
Reporting/when | Reported date: | 0..1 | date | ||
Medication/footer | null | 0..1 | group | ||
Medication/footer.0 | AHRQ Common Formats - Hospital Version 1.2 - 2012 Medication or Other Substance | 0..1 | display | ||
Documentation for this format |
ValueSet #ll2654-3
http://loinc.org
Code | Display |
LA20271-5 | Medications |
LA20335-8 | Biological products |
LA20336-6 | Nutritional products |
LA20337-4 | Expressed human breast milk |
LA20338-2 | Medical gases (e.g., oxygen, nitrogen, nitrous oxide) |
LA20339-0 | Contrast media |
LA20340-8 | Radiopharmaceuticals |
LA20341-6 | Patient food (not suspected in drug-food interactions) |
LA20342-4 | Drug-drug, drug-food, or adverse drug reaction as a result of a prescription and/or administration of a drug and/or food prior to admission |
LA20343-2 | Other substance: PLEASE SPECIFY |
ValueSet #ll2655-0
http://loinc.org
Code | Display |
LA20278-0 | Prescription or over-the-counter (including herbal supplements) |
LA20298-8 | Compounded preparations |
LA20299-6 | Investigational drugs |
LA4489-6 | Unknown |
ValueSet #ll2657-6
http://loinc.org
Code | Display |
LA20283-0 | Vaccines |
LA20287-1 | Other biological products (e.g., thrombolytic) |
ValueSet #ll2659-2
http://loinc.org
Code | Display |
LA20273-1 | Dietary supplements (other than vitamins or minerals) |
LA16117-6 | Vitamins or minerals |
LA20320-0 | Enteral nutritional products, including infant formula |
LA20321-8 | Parenteral nutritional products |
LA20318-4 | Other: PLEASE SPECIFY |
ValueSet #ll2660-0
http://loinc.org
Code | Display |
LA20275-6 | Incorrect action (process failure or error) (e.g., such as administering overdose or incorrect medication) |
LA20314-3 | Unsafe condition |
LA20315-0 | Adverse reaction in patient to the administered substance without any apparent incorrect action |
LA4489-6 | Unknown |
ValueSet #ll2661-8
http://loinc.org
Code | Display |
LA20276-4 | Incorrect patient |
LA20302-8 | Incorrect medication/substance |
LA20303-6 | Incorrect dose(s) |
LA20304-4 | Incorrect route of administration |
LA20305-1 | Incorrect timing |
LA20306-9 | Incorrect rate |
LA20307-7 | Incorrect duration of administration or course of therapy |
LA20308-5 | Incorrect dosage form (e.g., sustained release instead of immediate release) |
LA20309-3 | Incorrect strength or concentration |
LA20310-1 | Incorrect preparation, including inappropriate cutting of tablets, error in compounding, mixing, etc. |
LA20311-9 | Expired or deteriorated medication/substance |
LA20312-7 | Medication/substance that is known to be an allergen to the patient |
LA20345-7 | Medication/substance that is known to be contraindicated for the patient |
LA20313-5 | Incorrect patient/family action (e.g., self-administration error) |
LA20318-4 | Other: PLEASE SPECIFY |
ValueSet #ll2662-6
http://loinc.org
Code | Display |
LA20277-2 | Overdose |
LA20300-2 | Underdose |
LA20301-0 | Missed or omitted dose |
LA7271-5 | Extra dose |
LA4489-6 | Unknown |
ValueSet #ll2663-4
http://loinc.org
Code | Display |
LA20280-6 | Too early |
LA20290-5 | Too late |
LA4489-6 | Unknown |
ValueSet #ll2664-2
http://loinc.org
Code | Display |
LA20282-2 | Too quickly |
LA20288-9 | Too slowly |
LA4489-6 | Unknown |
ValueSet #ll2665-9
http://loinc.org
Code | Display |
LA20281-4 | Too high |
LA20289-7 | Too low |
LA4489-6 | Unknown |
ValueSet #ll2817-6
http://loinc.org
Code | Display |
LA33-6 | Yes |
LA32-8 | No |
LA4489-6 | Unknown |
ValueSet #ll2668-3
http://loinc.org
Code | Display |
LA20274-9 | Drug-drug |
LA20316-8 | Drug-food |
LA20317-6 | Drug-disease |
LA20318-4 | Other: PLEASE SPECIFY |
ValueSet #ll2669-1
http://loinc.org
Code | Display |
LA20279-8 | Purchasing |
LA20291-3 | Storing |
LA20292-1 | Prescribing/ordering |
LA20293-9 | Transcribing |
LA20294-7 | Preparing |
LA20295-4 | Dispensing |
LA20296-2 | Administering |
LA20297-0 | Monitoring |
LA4489-6 | Unknown |
LA20318-4 | Other: PLEASE SPECIFY |
ValueSet #ll2828-3
http://loinc.org
Code | Display |
LA33-6 | Yes |
LA32-8 | No |
ValueSet #ll2682-4
http://loinc.org
Code | Display |
LA20272-3 | Cutaneous, topical application, including ointment, spray, patch |
LA9451-1 | Subcutaneous |
LA9444-6 | Ophthalmic |
LA20324-2 | Oral, including sublingual or buccal |
LA9445-3 | Otic |
LA9263-0 | Nasal |
LA9427-1 | Inhalation |
LA9437-0 | Intravenous |
LA9429-7 | Intramuscular |
LA9435-4 | Intrathecal |
LA9418-0 | Epidural |
LA20332-5 | Gastric |
LA9369-5 | Rectal |
LA9459-4 | Vaginal |
LA4489-6 | Unknown |
LA20318-4 | Other: PLEASE SPECIFY |